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ABSTRACT 
Objective: To evaluate the clinical presentation and outcome of 
imported malaria. 
Methods: A retrospective chart review was conducted of 
patients with imported malaria admitted to the Communicable 
Disease Centre (CDC), Singapore (a 130-bed tertiary referral 
center) from January 1992 to December 1993. An imported 
case was defined as a smear-positive infection that was 
acquired in another country. 
Results: Among 200 malaria patients hospitalized at CDC, 168 
imported cases (137 males and 31 females, 131 nonresidents 
and 37 residents) were studied. The mean age was 31.6 5 
10.5 years. The countries visited were India (49.4%), Indone- 
sia (16.7%), and Bangladesh (13%). Five patients had chemo- 
prophylaxis and 36 patients had experienced previous malaria 
infection. The predominant symptoms were fever (97.6%), chills 
(79.2%) and rigors (67.9%). Hepatomegaly was detected in 
56 (33.3%) and splenomegaly in 49 patients (29.2%). Plas- 
medium vivax was present in 132 patients, Plasmodium falci- 
pat-urn in 29, and mixed F1 vivav and F? falciparum in 7 patients. 
Parasitemia ranged from 0.1% to 8.0%. Of the vivax cases, 
130 were treated with chloroquine, followed by primaquine in 
123 patients. Quinine was given to 36 patients (29 falciparum 
malaria and 7 mixed infections). Median time to fever defer- 
vescence was 2 days. Complications occurred in three patients 
(2 with shock and 1 with pulmonary edema). According to 
World Health Organization gravity criteria, body temperature 
over 40°C was detected in six patients, bilirubinemia higher 
than 50 pmol/L in nine, parasitemia over 5% in five, glycemia 
less than 2.2 mmol/L in two patients. There were five relapses. 
No death was recorded. 
Conclusion: Plasmodium vivax is the most common cause of 
imported malaria, with the majority acquired from the Indian 
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subcontinent. Only a few patients presented with severe 
malaria. 
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Malaria still remains a leading cause of morbidity and 
mortality in the developing world.’ The increasing move- 
ment of travellers from developed countries to the 
malaria endemic tropical countries and the migration of 
workers from malaria endemic countries to the indus- 
trialized countries are responsible for the emergence of 
imported malaria.2 Malaria may pose a diagnostic chal- 
lenge to the physician who does not have experience 
with the disease. These cases also pose a therapeutic chal- 
lenge because of the emergence of multiple-drug-resis- 
tant Plasmodiunz falciparum in Southeast Asia.3 Malaria 
is now primarily an imported disease in Singapore. A total 
of 221 cases were reported in 1992 and 354 cases in 
1993 of which 100% and 82% were imported, respec- 
tively. There were two local outbreaks of vivax malaria in 
1993, originating from imported cases.* 
The objective of the present study was to evaluate 
the clinical presentation and outcome of imported 
malaria at the Communicable Disease Centre (CDC), Min- 
istry of Health, Singapore. 
PATIENTS AND METHODS 
The Communicable Disease Centre, a 130-bed hospital, 
is the only tertiary referral center for infectious diseases 
in Singapore. Medical records were retrospectively ana- 
lyzed of ail patients with imported malaria admitted to the 
CDC from January 1992 to December 1993. The patients 
were located from a computerized database of medical 
records that were analyzed for travel history, chemopro- 
phylaxis use, clinical features, species of Plasmodium 
detected, complications, treatment, and outcome. 
An imported case of malaria was defined as a smear- 
positive infection that was acquired in another country. 
Severe malaria was defined according to the World Health 
136 
Imported Malaria in Singapore / Oh et al 137 
Organization (WHO) criteria.5 The time to fever defer- 
vescence was defined as the interval from initiation of 
appropriate antimalarial treatment until the documenta- 
tion of normal body temperature for more than 24 hours. 
Significance testing between groups was done where 
applicable with Fisher’s exact test. 
RESULTS 
Of 200 patients with smear-positive malaria admitted to 
CDC during the 2-year study period, I68 (84%) fulfiied 
the definition of imported malaria and were included in 
the analyses. 
There were 137 male and 31 female patients (male- 
to-female ratio 4.4:1).The mean age was 31.6 t 10.5 years 
(range, 3-70 y). The 168 patients studied included 37 
(22%) local residents and 13 1 (78%) foreigners, consisting 
of tourists and no nimmigrant foreign workers flable 1). 
Four patients had underlying medical conditions: two 
had diabetes mellitus, one had hypertension, and one had 
ischemic heart disease. Chemoprophylaxis was used by 
five patients, three of whom developed vivax, and two fal- 
ciparum malaria. Most of the infections were acquired in 
India (49.4%), followed by Indonesia (16.7%), Bangladesh 
(13%), Thailand (7.7%), and Sri Lanka (5.4%) (see Table 1). 
Table 2 presents the clinical features of the patients 
at presentation. The predominant symptoms were fever, 
chills, and rigors. Hepatomegaly and splenomegaIy were 
the predominant signs. A majority of the patients 
reported fever of 2 to 7 days duration. At presentation, 
100 (59.5%) patients were thrombocytopenic (i.e., 
platelets <150,000/mm3) and 63 (37.5%) were anemic 
(Hb <12 g/dL). 
Plasmodium vivax was detected in 132 cases, Pfalci- 
parum in 29 cases and mixed infection (R vivax and E! 
falciparum) in 7 cases. Parasitemia ranged from 0.1% to 
8.0%. Five (3%) patients had parasitemia over 5%. 
Table 1. Epidemiologic Characteristics of Imported Malaria 
Characferistic 
Population group 
Local residents 
Foreigners 
Country of origin 
India 
Indonesia 
Bangladesh 
Thailand 
Sri Lanka 
Philippines 
Africa 
Others 
Chemoprophylaxis 
Received chemoprophylaxis 
None 
Unknown 
Previous history of malaria 
Number of Patients 
n= 168(%) 
37 (22) 
131 (78) 
83 (49.4) 
28 (16.7) 
22 (13.0) 
13 (7.7) 
9 (5.4) 
4 (2.4) 
4 (2.4) 
5 (3.0) 
5 (3.0) 
162 (96.4) 
1 (0.6) 
36 
Table 2. Clinical and Laboratory Findings at 
Presentation in Patients with Imported Malaria 
Findings 
Number of Patients 
n=168(%) 
Clinical symptoms 
Fever 
Chills 
Rigors 
Arthralgia 
Diarrhea 
Abdominal pain 
Clinical signs 
Hepatomegaly 
Splenomegaly 
Pallor 
Jaundice 
Laboratory 
Thrombocytopenia 
i 150,000 / mm3 
< 50,000 / mm3 
Leukopenia 
< 3500 / mm3 
Anemia 
< 12 g/dL 
Hypoglycemia 
< 3.6 mmol/L 
Urea 
> 7 mmol/L 
Creatinine 
> 140 pmol/L 
164(97.6) 
133 (79.2) 
114 (67.9) 
13 (7.7) 
11 (6.5) 
11 (6.5) 
56 (33.3) 
49 (29.2) 
29 (17.3) 
15 (8.9) 
100 (59.5) 
32 (19.0) 
10 (6.0) 
63 (37.5) 
5 (3.0) 
29 (17.3) 
4 (2.4) 
Chloroquine was administered to 130 patients with 
vivax malaria; of these, 123 patients received additional 
primaquine. Quinine was given to 36 patients (29 with 
falciparum malaria and 7 with mixed infections), 
sulfadoxine-pyrimethamine and mefloquine each were 
Table 3. Therapy and Outcome in 
168 Patients with Imported Malaria 
Therapy or Outcome 
Number of Patients 
n=168(%%) 
Antimalarial therapy 
Chloroquine 
Chloroquine + primaquine 
Sulfadoxine-pyrimethamine 
Mefloquine 
Quinine (including 3 with additional doxycycline 
and 14 with additional tetracycline) 
Days to fever defervescence (median) 
Complications 
Shock 
Pulmonary edema 
Outcome 
Cure 
Relapse 
Death 
WHO gravity criteria: 
Body temperature > 40°C 
Bilirubinemia > 50 kmol/L 
Parasitemia > 5% 
Consciousness impairment 
Systolic blood pressure < 70 mmHg 
Hypoglycemia < 2.2 mmol/L 
Hemoglobin < 5 g/dL 
Renal failure (serum creatinine > 140 kmol/L) 
7 (4.2) 
123 (73.2) 
1 (0.6) 
1 (0.6) 
36 (21.4) 
2 
2 (1.2) 
1 (0.6) 
162 (96.4) 
5 (3.0) 
0 
6 (3.6) 
9 (5.4) 
5 (3.0) 
0 
i (1.2) 
: (2.4) 
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administered to one patient (Table 3). None required 
exchange transfusion. 
All patients recovered and no death was recorded. 
Five patients with vivax malaria suffered relapse, two of 
whom had been noncompliant with primaquine treat- 
ment. The mean time to fever defervescence was 2 days. 
Of the three patients who developed complications, one 
of the two patients with shock and the only patient with 
pulmonary edema had falciparum malaria (see Table 3). 
According to the WHO gravity criteria, body tem- 
perature over 40°C was detected in six patients, biliru- 
binemia over 50 kmol/L in nine, parasitemia over 50% in 
five, glycemia less than 2.2 mmol/L in two patients, and 
serum creatinine over 140 pmol/L in four patients (see 
Table 3).j 
DISCUSSION 
In spite of vigorous efforts to eradicate malaria, there are 
about 300 to 500 million cases reported yearly, with 80% 
of these occurring in sub-Saharan Africa.6 Imported 
malaria commonly is diagnosed in other industrialized 
countries that, like Singapore, have had successful malaria 
eradication programs.‘zs 
Malaria is a notifiable infectious disease in Singapore, 
where it is usually an imported disease occurring in Sin- 
gaporeans who visit or work in endemic areas and in 
nonimmigrant foreign workers, mainly from Indonesia 
and the Indian subcontinent. 
In this study, there were 200 patients with smear- 
positive malaria admitted to the CDC in 1992 and 1993, 
in whom 84% of cases were imported. This accounts for 
35% of total malaria cases and conforms to the average 
of 90 to 95% imported malaria cases reported in Singa- 
pore during the 2-year study period. 
Chemoprophylaxis was used in only five patients; 
97% of patients travelled without chemoprophylaxis. It 
has been suggested that chemoprophylaxis has been asso- 
ciated with less frequent severe malaria and lower para- 
sitemia.“JO Foreign workers as a group are less likely to 
take necessary preventive measures for visits to their 
countries of origin. More attention should be devoted to 
Singaporean travellers when promoting the importance 
of malaria prevention. The majority of individuals 
reported travel to India, Indonesia, and Bangladesh. This 
reflects the country of origin of many nonimmigrant for- 
eign workers in Singapore and the high incidence of 
malaria transmission throughout Asia. Indeed the risk of 
infection is highest in India, calculated to be 1: 1900 trav- 
ellers as compared to 1:4000 for Southeast Asia.” 
The frequency of clinical symptoms in the present 
study is consistent with findings in various studies except 
for a lower frequency of gastrointestinal symptoms.12.‘3 
Hepatomegaly and splenomegaly were the major physi- 
cal findings. About 60% of patients were thrombocy- 
topenic. Thrombocytopenia also has been noted fre- 
quently in previous studies.12J3 
Plasmodium vivax was the species most often iden- 
tified (78.5%) in the present study. Other studies have 
noted an increase in falciparum malaria in recent 
years.13J4 These differences can be explained by the pre- 
vailing destination of travel. Most cases of J? vivax in this 
study originated in Asia, which is the preferred destina- 
tion of the Singapore traveller, whereas in the other stud- 
ies, the falciparum infection was acquired in Africa. 
Falciparum malaria is known to cause more serious 
illness, with symptoms varying from a mild flu-like illness 
to severe hemolysis and multiorgan failure. All five 
patients with parasitemia over 5% and three of the four 
patients with raised serum creatinine (> 140 Fmol/L) had 
falciparum malaria. Parasitemia appears to be a reliable 
prognostic factor. 
Complications were detected in three patients, 
namely shock and pulmonary edema. Cerebral malaria 
did not occur in this series, and no death was recorded. 
Only a few of the patients presented with severe malaria, 
which probably explains the absence of fatality. Other 
studies report a fatality rate around 1%.15,16 
The majority of patients with vivax malaria were 
treated with chloroquine and primaquine. Quinine in 
combination with tetracycline was the main antimalarial 
treatment for falciparum malaria. In the follow-up of 107 
patients at 4 weeks, relapses were detected in five patients 
with vivax malaria. Only two of these five patients required 
re-admission for treatment. Travellers to malaria endemic 
areas should receive malaria prophylaxis, and patients with 
malaria should receive adequate treatment according to 
the drug-resistance patterns in that region. 
CONCLUSIONS 
This study has defined the characteristics of imported 
malaria in Singapore. Plasmodium vivax is the most com- 
mon cause of imported malaria, with the majority of cases 
acquired from the Indian subcontinent. Singapore is both 
vulnerable and receptive to the re-introduction of malaria 
because of the constant influx of travellers and foreign 
workers and the presence of the Anopheles vector. It is 
vital that pre-travel advice on pre-exposure chemopro- 
phylaxis and personal protection measures be provided, 
especially to travellers visiting the Indian subcontinent, 
since malaria is, to a large extent, a preventable disease. 
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